HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,018,891 | +29.1% | 33,701 | +22.7% | 0.00% | 0.0% |
Q2 2023 | $2,338,796 | +11.8% | 27,470 | -93.2% | 0.00% | 0.0% |
Q1 2023 | $2,091,480 | -6.1% | 406,531 | +1335.9% | 0.00% | 0.0% |
Q4 2022 | $2,226,739 | +10.5% | 28,312 | +4.0% | 0.00% | 0.0% |
Q3 2022 | $2,016,000 | +27.8% | 27,234 | +12.6% | 0.00% | 0.0% |
Q2 2022 | $1,577,000 | +0.9% | 24,189 | -2.1% | 0.00% | 0.0% |
Q1 2022 | $1,563,000 | +92.7% | 24,716 | +61.6% | 0.00% | – |
Q4 2021 | $811,000 | -29.0% | 15,299 | -5.5% | 0.00% | -100.0% |
Q3 2021 | $1,143,000 | -10.6% | 16,189 | -15.6% | 0.00% | 0.0% |
Q2 2021 | $1,278,000 | -62.3% | 19,175 | -37.3% | 0.00% | -50.0% |
Q1 2021 | $3,394,000 | -4.2% | 30,572 | +2.5% | 0.00% | -33.3% |
Q4 2020 | $3,542,000 | +67.2% | 29,824 | +22.8% | 0.00% | +50.0% |
Q3 2020 | $2,118,000 | +46.6% | 24,279 | +50.4% | 0.00% | +100.0% |
Q2 2020 | $1,445,000 | +7.7% | 16,139 | +19.9% | 0.00% | -50.0% |
Q1 2020 | $1,342,000 | +15.6% | 13,464 | +33.2% | 0.00% | +100.0% |
Q4 2019 | $1,161,000 | -4.0% | 10,105 | +5.3% | 0.00% | 0.0% |
Q3 2019 | $1,210,000 | +98.4% | 9,594 | +89.1% | 0.00% | 0.0% |
Q2 2019 | $610,000 | +81.0% | 5,073 | +31.7% | 0.00% | – |
Q1 2019 | $337,000 | -76.4% | 3,852 | -73.0% | 0.00% | -100.0% |
Q4 2018 | $1,430,000 | -11.6% | 14,293 | -20.8% | 0.00% | -50.0% |
Q2 2018 | $1,618,000 | -14.8% | 18,049 | -30.5% | 0.00% | -20.0% |
Q1 2018 | $1,899,000 | +22.6% | 25,955 | -2.7% | 0.01% | +66.7% |
Q4 2017 | $1,549,000 | +29.8% | 26,665 | +0.3% | 0.00% | 0.0% |
Q3 2017 | $1,193,000 | +3.8% | 26,572 | -8.8% | 0.00% | 0.0% |
Q2 2017 | $1,149,000 | +11.8% | 29,140 | +14.9% | 0.00% | 0.0% |
Q1 2017 | $1,028,000 | +1.7% | 25,371 | +0.9% | 0.00% | -25.0% |
Q4 2016 | $1,011,000 | +10.3% | 25,146 | -0.7% | 0.00% | 0.0% |
Q3 2016 | $917,000 | +24.8% | 25,329 | -0.0% | 0.00% | +33.3% |
Q2 2016 | $735,000 | -25.2% | 25,337 | -9.8% | 0.00% | -25.0% |
Q1 2016 | $982,000 | +19.8% | 28,087 | +10.5% | 0.00% | 0.0% |
Q4 2015 | $820,000 | -4.3% | 25,429 | -4.1% | 0.00% | 0.0% |
Q3 2015 | $857,000 | -30.7% | 26,526 | -11.3% | 0.00% | -33.3% |
Q2 2015 | $1,237,000 | -22.5% | 29,899 | -15.8% | 0.01% | -25.0% |
Q1 2015 | $1,596,000 | +7154.5% | 35,530 | +5891.6% | 0.01% | – |
Q4 2014 | $22,000 | +4.8% | 593 | 0.0% | 0.00% | – |
Q3 2014 | $21,000 | +10.5% | 593 | +11.9% | 0.00% | – |
Q2 2014 | $19,000 | +90.0% | 530 | +71.5% | 0.00% | – |
Q1 2014 | $10,000 | -63.0% | 309 | -52.5% | 0.00% | – |
Q4 2013 | $27,000 | +80.0% | 650 | +68.0% | 0.00% | – |
Q3 2013 | $15,000 | -25.0% | 387 | -19.9% | 0.00% | – |
Q2 2013 | $20,000 | – | 483 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |